Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRNT1P1 is classified as a pseudogene, meaning it is a non-coding DNA sequence that is similar to the functional TRNT1 gene but generally does not produce a functional protein and does not play an active biological role. The functional gene, TRNT1, encodes the enzyme tRNA nucleotidyl transferase 1, which is essential for catalyzing the addition of the CCA trinucleotide sequence at the 3' end of tRNAs, a critical step for tRNA maturation in both cytoplasmic and mitochondrial compartments[1][2][3][4]. Mutations in the TRNT1 gene (not the pseudogene) are linked to multisystem disorders such as sideroblastic anemia with immunodeficiency, periodic fevers, retinitis pigmentosa, and developmental delay[1][3][4]. However, TRNT1P1 itself lacks evidence for expression, protein activity, or disease involvement, and is not recognized as a therapeutic target in biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRNT1 pseudogene 1 (TRNT1P1).